Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. . PLoS One 2021;16:e0255429.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLoS One 2021;16:e0255429.
PMID: 34297782